v3.26.3
Revenue Recognition (Tables)
9 Months Ended
Sep. 30, 2026
Revenue Recognition [Abstract]  
Schedule of Disaggregated Revenue
Net Sales by Business
Three Months
Nine Months
2026
2025
2026
2025
MedSurg and Neurotechnology:
Instruments
$996
$949
$2,919
$2,705
Endoscopy
1,021
896
2,893
2,662
Medical
1,081
985
3,105
2,920
Vascular
566
525
1,579
1,429
$3,664
$3,355
$10,496
$9,716
Orthopaedics:
Knees
$635
$628
$1,998
$1,907
Hips
453
457
1,392
1,366
Trauma and Extremities
1,010
960
3,117
2,862
Ortho Tech
754
651
2,117
1,917
Spinal Implants
4
6
9
$177
$2,856
$2,702
$8,633
$8,229
Total
$6,520
$6,057
$19,129
$17,945
Net Sales by Geography
Three Months
Nine Months
2026
2025
2026
2025
United States
$4,950
$4,571
$14,385
$13,565
International
1,570
1,486
4,744
4,380
Total
$6,520
$6,057
$19,129
$17,945
Contract with Customer, Contract Asset, Contract Liability, and Receivable Changes in contract liabilities during the nine months 2026 were
as follows:
September 30
2026
Beginning contract liabilities
$1,024
Revenue recognized from beginning of year contract liabilities
(615)
Net advance consideration received during the period
551
Ending contract liabilities
$960